Curt Blacklock, DO
Internal Medicine · Newark, DENPI 1467465450
Payments from drug & device makers
Across 608 payments — averaging $17.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Amgen$1K
- GSK$1K
- AbbVie$1K
- Novo Nordisk$1K
- Lilly USA, LLC$641
- plus $3K from 28 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 80 | $1,494 |
| Amgen | 73 | $1,467 |
| GSK | 80 | $1,380 |
| AbbVie | 56 | $1,177 |
| Novo Nordisk | 68 | $1,068 |
| Lilly USA, LLC | 47 | $641 |
| Astellas Pharma US Inc | 38 | $589 |
| Pfizer | 28 | $506 |
| Abbott | 25 | $401 |
| Bayer | 18 | $339 |
| Merck | 22 | $303 |
| Johnson & Johnson | 12 | $189 |
| Exact Sciences | 8 | $131 |
| Idorsia Pharmaceuticals US Inc | 7 | $122 |
| Amarin Pharma, Inc. | 7 | $108 |
| Novartis | 6 | $93 |
| Eisai Inc. | 6 | $82 |
| Phathom Pharmaceuticals, Inc. | 2 | $81 |
| Scilex Pharmaceuticals Inc. | 4 | $78 |
| Kowa Pharmaceuticals America, Inc. | 4 | $48 |
| Dexcom, Inc. | 1 | $38 |
| Medtronic | 2 | $32 |
| Tactile Systems Technology Inc | 1 | $30 |
| Shire North American Group Inc | 2 | $29 |
| Endo Pharmaceuticals Inc. | 2 | $25 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| Shield Therapeutics Inc | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Sanofi Pasteur Inc. | 1 | $18 |
| Radius Health, Inc. | 1 | $17 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $16 |
| Seqirus USA Inc | 1 | $16 |
| Xeris Pharmaceuticals, Inc. | 1 | $15 |
| Linus Health, Inc. | 1 | $13 |
How this compares
$10,607 in reported general payments places this provider in the 95th percentile of 477 internal medicine providers in Delaware.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other internal medicine in Newark
- Seth IvinsNewark$384K
- Tabassum SalamNewark$62K
- John ReinhardtNewark$22K
- Shahzeb KhanNewark$14K
- Matthew JacobsonNewark$10K
- Reynold AgardNewark$8K
- Zouhair HarbNewark$7K
- Vivek ReddyNewark$6K
- Beshara HelouGeorgetown$143K
- Fabricio AlarconGeorgetown$30K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.